In the BioHarmony Drug Report Database

"Preview" Icon

Delamanid

Deltyba (delamanid) is a small molecule pharmaceutical. Delamanid was first approved as Deltyba on 2014-04-27. It has been approved in Europe to treat multidrug-resistant tuberculosis.

 

Trade Name

 

Deltyba
 

Common Name

 

delamanid
 

ChEMBL ID

 

CHEMBL218650
 

Indication

 

multidrug-resistant tuberculosis
 

Drug Class

 

Mycolic acid inhibitors

Image (chem structure or protein)

Delamanid structure rendering